DRIO

DarioHealth Corp.
CAPPED RATING

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the Company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Its cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease.

DarioHealth Corp. (DRIO) is rated C+ (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Momentum (D-). The rating has held at C+ for 7 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.5 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
B-
Factor Score 2.9 / 5.0
Profitability
B-
Factor Score 3.1 / 5.0
Momentum
D-
Factor Score 1.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -2.1
EV / EBITDA -1.4
Rev Growth YoY -3.6%
Gross Margin 61.6%
Price Return 3M -68.0%
Price Return 12M -80.9%
Catalyst Signal 0.00
Market Cap $23.4M
TTM Revenue $21.0M
Price / Sales 1.1
ROE -59.9%

Historical Factor Score Progression

Held C+ for 7 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 B- (3.0) B- (2.9) B- (3.1) D- (1.0) C+ (2.6) C+ (2.5)
2026-11-04 B- (3.0) B- (2.9) B- (3.1) D (1.2) C+ (2.7) C+ (2.6)
2026-10-28 B- (3.0) C+ (2.8) B- (3.1) D (1.5) C+ (2.7) C+ (2.6)
2026-10-21 B- (3.0) B- (2.9) B- (3.1) D+ (1.6) C+ (2.6) C+ (2.6)
2026-10-14 B- (3.0) B- (2.9) B- (3.1) C (2.2) C+ (2.6) C+ (2.8)
Page 1 of 8
…